High lung cancer surgical procedure volume is associated with shorter length of stay and lower risks of readmission and death: national cohort analysis in England.
ABSTRACT
It is debated whether treating cancer patients in high-volume surgical centres can lead to improvement in outcomes, such as shorter length of hospital stay, decreased frequency and severity of postoperative complications, decreased re-admission, and decreased mortality.
The dataset for this analysis was based on cancer registration and hospital discharge data and comprised information on 15,738 non-small cell lung cancer patients resident and diagnosed in England in 2006-2010 and treated by surgical resection. The number of lung cancer resections was computed for each hospital in each calendar year, and patients were assigned to a hospital volume quintile on the basis of the volume of their hospital.
Hospitals with large lung cancer surgical resection volumes were less restrictive in their selection of patients for surgical management, and provided a higher resection rate to their geographical population. Higher volume hospitals had shorter length of stay and the odds of re-admission were 15% lower in the highest hospital volume quintile compared with the lowest quintile. Mortality risks were 1% after 30 days and 3% after 90 days. Patients from hospitals in the highest volume quintile had about half the odds of death within 30 days than patients from the lowest quintile.
Variations in outcomes were generally small, but in the same direction, with consistently better outcomes in the larger hospitals. This gives support to the ongoing trend towards centralisation of clinical services, but service re-organisation needs to take account of not only the size of hospitals but also referral routes and patient access.
INTRODUCTION
Lung cancer is one of the most frequent types of cancer and the leading cause of cancer death globally. [1, 2] There has been notable progress in lung cancer prevention, as evidenced by declining incidence rates in males, [3] and treatment for lung cancer has become more active and more effective. [4] [5] [6] Surgical resection remains the preferred treatment option for medically fit patients with early-stage disease. [7] [8] [9] [10] Lung cancer surgery is highly specialised and increasingly centralised. [5] There is evidence that patient survival is better when surgical care is provided by a multi-disciplinary team in hospitals with high-volume practices, and analysis of surgical data from England in patients diagnosed in 2004-2008 showed lower death rates in patients operated in large-volume hospitals. [11] It remains to be addressed whether treating patients in high-volume surgical centres can lead to improvement in other relevant outcomes, such as shorter length of hospital stay, decreased frequency and severity of postoperative complications, decreased re-admission to hospital, and improved patient experience and satisfaction. The present study extends earlier work on patients undergoing lung cancer surgery in England to examine other outcomes, specifically length of stay in hospital after lung cancer resection, and risks of re-admission and death within 30 and 90 days of surgery.
METHODS

Study population and main predictor variables
The principles of data extraction and linkages were as described previously. [9, 11] The dataset for the analysis comprised information on 15,738 non-small cell lung cancer patients who were resident and diagnosed in England in 2006-2010 and treated by potentially curative surgical resection as part of their initial care. The majority of resections were lobectomy (85%); 10% were pneumonectomy and 5% were other procedures. This is a complete and population-based ascertainment of surgically treated lung cancer in the country. The number of lung cancer resections was computed for each hospital in each calendar year, and patients were assigned to a hospital volume quintile on the basis of the volume of their hospital in the year of diagnosis.
The geographical resection rate was computed as the resected proportion of all non-small cell lung cancer patients in each of 152 geographical primary care trust areas in the period 2006-2010. [9] Covariates Sex and age were analysed as categorical variables (age categorised in five-year groups). 
Outcomes
Outcome variables were the length of stay in hospital (in days) at the time of the surgical resection for lung cancer, re-admission as an in-patient to any hospital, regardless of the reason for admission, within 30 and 90 days among the patients who were discharged to their home after the lung cancer resection, and death within 30 and 90 days from the date of surgery.
Statistical analysis
Length of hospital stay distribution was described by the means, and the means of logtransformed values (called the 'log-average' length of stay). Length of stay was analysed in relation to hospital volume quintile and covariates by linear regression of log-transformed length of stay. A two-level linear regression model was fitted with the individual patient as the lower level and a random effect of hospital as the higher level. The risks of re-admission and death were analysed in relation to hospital volume quintile with univariate and multivariate logistic regression analysis. Two-level logistic regression models were fitted with hospital as a random effect. The covariates that were used in adjusted analyses were: geographical resection rate, age, co-morbidity, performance status, stage, histology and ethnicity using categorical variables as described in Table 1 . 1B  2793  18  520  16  588 18  536  18  542  17  607 20  2A  493  3  79  2  101  3  73  2  100  3  140  5  2B  1390  9  280  9  273  8  263  9  274  9  300 10  3A  1101  7  189  6  188  6  204  7  246  8  274  9  3B  476  3  91  3  95  3  89  3  103  3  98  3  4  417  3  92  3  70  2  63  2  92  3  100  3  NA  6649  42  1450  45 1422 44 1384  46 1359  43 1034 Table 1 gives an overview of the study cohort of 15,738 lung cancer patients diagnosed in the period 2006-2010 in England and treated with surgical resection. Table 1 shows the marginal distributions of the variables in the analysis, and crosstabulations between the quintile of lung cancer surgical procedure volume (the principal independent variable) and covariates. A high annual hospital volume was strongly associated with a high geographical resection rate (χ2=538.2; p<0.0001). There was no association between hospital volume and sex of the patient, but high-volume hospitals had a higher proportion of older patients (χ2=14.2; p=0.0002). There was no association with socio-economic status but there were slightly more co-morbid patients in high-volume hospitals (χ2=4.1; p=0.04). High-volume hospitals had more complete reporting of performance status and tumour stage than low-volume hospitals, and they used the unspecific histology code "Non-small cell lung cancer (NSCLC)" less frequently. Within the patients with non-missing performance status, the high-volume hospitals had a higher proportion of patients with poor performance status (2 or higher) (χ2=14.3; p=0.0002) (Appendix table) . Table 2 shows the length of stay in hospital during the hospitalisation where the lung cancer resection took place. The average length of stay was 9.82 days in the quintile with the lowest hospital volume and 9.35 days in the highest-volume quintile. The linear regression of log-transformed length of stay on hospital volume quintile suggested that the difference in length of stay was about 0.3 days between the extreme quintiles. This gradient was statistically significant with a negative slope (p=0.004). Adjustment for the covariates that were associated with resection quintile (geographical resection rate, age, co-morbidity, performance status, stage, histology and ethnicity) made the regression slope marginally steeper, reflecting the more adverse case-mix of patients in high-volume hospitals. A twolevel adjusted regression model with the individual hospital as a random effect reduced the statistical significance of the association between hospital volume and length of hospital stay (data not shown). Hospital volume in relation to re-admission and mortality Table 3 shows the associations between hospital volume quintile and the risk of readmission as an in-patient to a hospital and the risk of mortality, each within 30 and 90 days of surgery. Patients operated in high-volume hospitals had lower re-admission risks (19% in quintile 5 vs. 22% in quintile 1 for 30-day readmission, p for trend over the five quintiles: p=0.08; and 44% vs. 47% for 90-day readmission, p<0.0001). Similarly, mortality risk were lower in high-volume hospitals (0.5% vs. 1.0% within 30 days, p=0.01; and 2.2% vs. 3.1% within 90 days, p=0.02). Table 4 shows the more detailed analyses of 30-day and 90-day readmission risks in relation to hospital volume quintile. Statistical adjustment for geographical resection rate, age, co-morbidity, performance status, stage, histology and ethnicity strengthened the associations between hospital volume and 30-day and 90-day readmission risks. Further allowance for the two-level structure of the data by fitting a random effect of individual hospital further strengthened the association with 30-day re-admission risk, but the association with 90-day readmission was much attenuated in the two-level model. Table 5 shows the detailed analyses of 30-day and 90-day mortality outcomes. For both endpoints, higher hospital volume was associated with lower risks of death, and this did not change much with adjustment for covariates or with the allowance for variation between hospitals. , and also allowing for variation in mortality between individual hospitals.
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DISCUSSION
Interpretation of the results of adjusted analyses and two-level analyses
The principal findings of these analyses are:
1: Hospitals with large lung cancer surgical resection volumes are less conservative in their selection of patients for surgical management, and they provide a higher resection rate to their geographical population. The results suggest that there are systematic differences between smaller and larger hospitals that facilitate better patient outcomes in the larger hospitals, despite their more inclusive criteria for selection and the resulting adverse case-mix. In addition, it seems that the culture of data collection is better in the larger hospitals where completeness of recording of stage and performance status is highest. Other variations, not currently captured in the cancer register, may be availability of staging methods (e.g.
endoscopic ultrasound and PET scanning) and the systematic use of adjuvant chemotherapy.
Comparison with other studies
The analyses of 30-day and 90-day mortality risks in relation to hospital volume are consistent with previous analyses of hazard ratios for death. [11] The analyses of mortality outcomes in lung cancer patients in England in relation to surgical procedure volume adds to the growing body of evidence of favourable outcomes in high-volume hospital settings. [11, [13] [14] [15] [16] It is noteworthy that the 30-day mortality outcome is insufficient to capture the full mortality effect, and that 90-day mortality is more than three times the magnitude of 30-day mortality (2.8% vs. 0.9%). Similar findings were reported in a large study in the USA. [17] This emphasises that mortality outcomes should be considered both in the short and the longer term. [11] The results for length of stay and re-admission emphasise that these outcomes vary along the gradient from low hospital volume (and high mortality) to high volume (and lower mortality). Recent studies have explored associations within the wider set of outcomes: hospital volume, length of stay, complications, readmission, mortality, and cost. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] The emerging pattern is one of correlated and consistently favourable outcomes in high-volume hospitals. We are not aware of any studies of patient-reported outcomes and patient experience in relation to hospital volume, which should be an area for further research.
Threshold of effects?
It has been considered whether the associations with hospital volume would be characterised by a threshold above which increasing hospital volume would not provide any further increase in clinical benefit. [31] The present analysis was not designed to establish a threshold value. We consider that such analysis should pre-specify the hypothetical threshold value, and then proceed similarly to a formal equivalence trial. [32] Regardless, the present data suggests that there may well be different thresholds (if any) for different outcomes. Length of hospital stay and re-admission risks are numerically similar in quintiles 4 and 5 (i.e. above a possible threshold around 150 procedures per year), but in the analysis of mortality risks the data would suggest continued increase in benefit above around 190 procedures per year.
The structure of health care systems and models of care vary between countries, and it is not necessarily the case that associations with procedure volume would be similar between countries or that any thresholds would be the same. For example, the large study of lung cancer resection in the USA [17] considered 90 procedures per year as the cut-off point for their high-volume group of patients, but this falls within the second quintile in the present data and would be considered as a low volume in England.
Strengths and limitations
The present analysis benefit from systematically collected data with uniform standards and classifications in a large national population. The quality and completeness of cancer registration data in England have improved in recent years, and tumour stage is now available in the majority of cases. Ascertainment of outcomes is based on routinely collected data and unlikely to differ artifactually between hospitals with different practice volume. However, the use of routinely collected data is also the main limitation of the study, and information on co-morbidity, performance status and histology are subject to a higher degree of error than we would expect from a smaller study based on more fully quality-assured clinical data.
The 30 and 90-day re-admission rates are remarkably high regardless of which type of hospital treated the patients. The data does not define why the patients were re-admitted, which may be for reasons other than for management of post-operative complications.
We note that a high number of hospitals contribute to this data set. The record linkages identified the combination of lung cancer registration and a relevant surgical resection in patients with resection reported from 78 hospitals, but these resections should mainly or entirely take place in the 30 thoracic centres in England. [6] The data set includes a number of hospitals that contributed only a single or a few records to the data set. We have no means of quality assuring these records which for a large part may be due to errors of coding and registration. These hospitals with very few resections are all in quintile 1 of the hospital procedure volume grouping, and make up a small proportion of the 3190 patients in this group.
We can judge the magnitude and direction of possible bias from the inclusion of these records by looking at associations across quintiles 2-4. Such restriction strengthens the association with length of stay ( Table   2 ) and with mortality (Table 5) , and it has little or no impact on the analysis of readmission risks (Table 4) .
These findings support the view that the principal problem is too few lung cancer patients gaining access to a thoracic surgical service. The ultimate validation of this conjecture may require the collection of more detailed information on patient preferences, local clinical policies and decision making processes than are available in the routine cancer registration system.
Are the observed differences clinically relevant?
We have described differences in bed-days, readmissions and deaths in terms of a relative measure (the odds ratio), Chi-square measures of association, and associated p-values. These standard measures allow for testing of the a priori hypotheses of association, but tells us little about the clinical and practical relevance of the observed variations in outcomes. In order to address this we computed (from the data in Tables 2 and 3 ) the total counts of bed-days, readmissions and deaths, and the number and proportion of these that would have been avoided if the patients in hospital volume quintiles 1-4 had experienced the same (lower) bed-days and risks as the patients in quintile 5.
In absolute terms, the strongest signal in these data is found for 30-day post-operative mortality. Of the 145 deaths that were observed, 65 deaths (45%) would have been avoided if the 12,635 patients in quintiles 1-4 had experienced the low 0.5% mortality risk of the 3103 patients in quintile 5.
Similar calculations show that 24% of the 90-day post-operative deaths are attributable to the variation in 90-day mortality between the quintiles, but for bed-days and readmissions, the proportions so attributable are only a few percent and each of these variations are not of practical relevance. It remains important that all the variations are in the same direction, with consistent better outcomes in high-volume hospitals.
Crawford et al [33] looked at the socio-economic status of patients and the distance they lived both from the diagnostic and the surgical centre. Patients who lived far from the surgical centre had lower rate of surgery than those who lived closer to the centre. Likewise, Khakwani et al [6] showed that surgical centres with large catchment areas resected a high proportion of patients referred directly to the centre, but a smaller proportion of the patients referred to them from other hospitals. So, service re-organisation needs to take account of not only the size of hospitals but also referral routes and patient access. [34] 
